1 3 Table 1 Patient characteristics in all patients, non-CAD and CAD groups Continuous variables are expressed as mean ± SD. When continuous variables did not show a normal distribution, the variables are expressed as a median value and interquartile range CAD coronary artery disease, BMI body mass index, HTN hypertension, DM diabetes mellitus, DL dyslipidemia, CKD chronic kidney disease, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c glycosylated hemoglobin A1c, UA uric acid, eGFR estimated glomerular filtration rate, PCSK9 pro-protein convertase subtilisin/kexin type 9, ARB angiotensin II receptor blocker, ACE-I angiotensin-converting enzyme inhibitor, CCB calcium channel blocker, BB beta-blocker, DU diuretic, SU sulfonylurea, BG biguanide, DPP4-I dipeptidyl-peptidase 4 inhibitor 
10 (27) 11 (14) 10 ( 
